Crystal structure of ethyl (2S)-9-meth­oxy-2-methyl-4-oxo-3,4,5,6-tetra­hydro-2H- 2,6-methano­benzo[g][1,3,5]oxa­diazocine-11-carboxyl­ate

Dhandapani A.; Manivarman S.; Subashchandrabose S.; Gunasekaran B.

首页> 外文期刊>Acta Crystallographica Section E: Crystallographic Communications >Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate

【24h】

Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate

机译：乙基（2S）-9-甲氧基-2-甲基-4-氧代-3,4,5,6-四氢-2H- 2,6-甲基苯并[g] [1,3,5]恶二唑啉-11的晶体结构-羧酸盐

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

In the title compound, C15H18N2O5, the methoxyphenyl ring makes a dihedral angle of 84.70 (12)° with the mean plane of the tetrahydropyrimidin-2(1H)-one ring. Both the pyran and tetrahydropyrimidin-2(1H)-one rings have distorted envelope conformations with the carboxylate-substituted C atom as the flap. In the crystal, molecules are linked via pairs of N—H⋯O hydrogen bonds, forming zigzag chains propagating along [010], which enclose R22(8) ring motifs. The chains are linked by C—H⋯π interactions, forming a two-dimensional network parallel to (100).

机译：在标题化合物C15H18N2O5中，甲氧基苯基环与四氢嘧啶-2（1H）-环的平均平面成84.70°（12）°的二面角。吡喃和四氢嘧啶-2（1H）-一环都具有被羧酸酯取代的C原子作为瓣的扭曲的包膜构象。在晶体中，分子通过成对的N-H = O氢键连接，形成沿[010]传播的Z字形链，其中包含R22（8）环基序。链通过CH键相互作用，形成平行于（100）的二维网络。

著录项

来源
《Acta Crystallographica Section E: Crystallographic Communications》 |2015年第2期|共页
作者
Dhandapani A.; Manivarman S.; Subashchandrabose S.; Gunasekaran B.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类晶体学;
关键词

相似文献

外文文献
中文文献
专利

1. Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate [J] . Dhandapani A., Manivarman S., Subashchandrabose S., Acta Crystallographica Section E: Crystallographic Communications . 2015,第2期

机译：乙基（2S）-9-甲氧基-2-甲基-4-氧代-3,4,5,6-四氢-2H- 2,6-甲基苯并[g] [1,3,5]恶二唑啉-11的晶体结构-羧酸盐
2. Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate [J] . Dhandapani A., Manivarman S., Subashchandrabose S., Acta Crystallographica Section E: Crystallographic Communications . 2015,第2期

机译：乙基（2S）-9-甲氧基-2-甲基-4-氧代-3,4,5,6-四氢-2H- 2,6-甲基苯并[g] [1,3,5]恶二唑啉-11的晶体结构-羧酸盐
3. Spontaneous resolution and crystal structure of (2S)-2-(3-nitrophenyl)-3-phenyl-2,3,5,6-tetrahydro-4H-1,3-thiazin-4-one; crystal structure of rac-2-(4-nitrophenyl)-3-phenyl-2,3,5,6-tetrahydro-4H-1,3-thiazin-4-one [J] . Yennawar H.P., Bradley H.G., Perhonitch K.C., Acta Crystallographica Section E: Crystallographic Communications . 2018,第4期

机译：（2S）-2-（3-硝基苯基）-3-苯基-2,3,5,6-四氢-4H-1,3-噻嗪-4-酮的自发拆分和晶体结构; rac-2-（4-硝基苯基）-3-苯基-2,3,5,6-四氢-4H-1,3-噻嗪-4-酮的晶体结构
4. Crystal Structure, Dielectric and Magnetic properties of Oxalate-Bridged MnCr Complex with Supramolecular Cation of (Anilinium Derivatives)(Benzo18crown-6) [C] . Jiabing Wu, Kiyonori Takahashi, Norihisa Hoshino 日本化学会春季年会講演予稿集 . 2018

机译：具有（苯锆衍生物）的超分子阳离子（苯并18 Crown-6）的草酸桥锰配合物的晶体结构，介电和磁性特性
5. Crystal structures of ethyl (2S*2′R*)-1′-methyl-2′′3-dioxo-23-dihydrodispiro1-benzothiophene-23′-pyrrolidine-2′3′′-indoline-4′-carboxylate and ethyl (2S*2′R*)-5′′-chloro-1′-methyl-2′′3-dioxo-23-dihydrodispiro1-benzothiophene-23′-pyrrolidine-2′3′′-indoline-4′-carboxylate [O] . M. P. Savithri, M. Suresh, R. Raghunathan, 2014

机译：乙基（2S *2R *）-1-甲基-23-二氧-2-23-二氢二螺1-苯并噻吩-23-吡咯烷-23的晶体结构-二氢吲哚 -4-羧酸盐和乙基（2S *2R *）-5-氯-1-甲基-23-二氧代-23-二氢二螺并1-苯并噻吩-2 3-吡咯烷-23-二氢吲哚 -4-羧酸盐
6. Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate [O] . A. Dhandapani, S. Manivarman, S. Subashchandrabose, 2015

机译：（2s）-9-甲氧基-2-甲基-4-氧代-3,4,5,6-四氢-2H-2,6-甲基苯并[g] [1,3,5]恶二唑嗪-11的晶体结构 - 甲酸

Crystal structure of ethyl (2S)-9-meth­oxy-2-methyl-4-oxo-3,4,5,6-tetra­hydro-2H- 2,6-methano­benzo[g][1,3,5]oxa­diazocine-11-carboxyl­ate

摘要

著录项

相似文献

相关主题

期刊订阅

Crystal structure of ethyl (2S)-9-methoxy-2-methyl-4-oxo-3,4,5,6-tetrahydro-2H- 2,6-methanobenzo[g][1,3,5]oxadiazocine-11-carboxylate